Vincent van der Velden

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

Rob Pieters, Hester de Groot‐Kruseman, Vincent van der Velden et al. · Journal of Clinical Oncology · 2016 · 370 citations · Full text

Medicine, Oncology, Pediatrics +16

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

T Flohr, André Schrauder, Giovanni Cazzaniga et al. · Leukemia · 2008 · 360 citations

Medicine, Hematology, Oncology +15

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten et al. · Haematologica · 2017 · 94 citations · Full text

Medicine, Hematology, Oncology +17

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome

Michaela Nováková, Markéta ŽAliová, Martina Suková et al. · Haematologica · 2016 · 70 citations · Full text

Medicine, Hematology, Pediatrics +17

Fluorochrome choices for multi-color flow cytometry

Juan Flores‐Montero, Tomáš Kalina, Alba Corral-Mateos et al. · Journal of Immunological Methods · 2019 · 53 citations

Natural Sciences, Cell Biology, Analytical Chemistry +12